- $34.41bn
- $30.20bn
- $2.46bn
- 96
- 10
- 78
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,400 | 1,659 | 1,944 | 2,182 | 2,455 |
Cost of Revenue | |||||
Gross Profit | 1,110 | 1,350 | 1,587 | 1,768 | 1,964 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,025 | 1,370 | 1,512 | 1,731 | 2,173 |
Operating Profit | 375 | 289 | 432 | 451 | 282 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 391 | 271 | 404 | 486 | 501 |
Provision for Income Taxes | |||||
Net Income After Taxes | 315 | 227 | 293 | 369 | 375 |
Net Income Before Extraordinary Items | |||||
Net Income | 315 | 227 | 293 | 369 | 375 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 315 | 227 | 293 | 369 | 375 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.836 | 0.593 | 0.742 | 0.929 | 0.921 |